Net revenues (Tables)

6 Months Ended

Jun. 30, 2019

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Major Customers by Reporting Segments

The following table disaggregates revenue by global product category for the three and six months ended June 30, 2019 and July 1, 2018.

	Three Months Ended				Six Months Ended
	June 30, 2019		July 1, 2018		June 30, 2019		July 1, 2018
	(Dollars in thousands)
Vascular access	$	153,647	$	140,149	$	297,544	$	284,177
Anesthesia	85,723		89,311		165,975		174,233
Interventional	104,785		98,189		207,969		188,331
Surgical	95,570		90,517		182,289		176,138
Interventional urology	67,952		47,674		127,683		89,974
OEM	56,428		52,594		110,666		98,448
Other (1)	88,402		91,432		173,965		185,795
Net revenues (2)	$	652,507	$	609,866	$	1,266,091	$	1,197,096

(1) Revenues in the "Other" category in the table above include revenues generated from sales of the Company’s respiratory and urology products (other than interventional urology products). For the three and six months ended June 30, 2019, the Company reclassified its cardiac products from "Other" to "Interventional". The comparative prior year period has been restated to conform to the current period presentation.

(2)

The product categories listed above are presented on a global basis; in contrast, each of the Company’s reportable segments other than the OEM reportable segment are defined exclusively based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the Company’s geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.